Skip to content

Gianluca A. Florineth

3 papers in the library · 1 citation · publishing 2025-2026

Papers

Sort Most recent Most cited

Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis

Journal of Psychopharmacology October 8, 2026 Gianluca A. Florineth, Anna L. Boeker, Tobias Bracht et al.

Background: Psilocybin-assisted therapy (PAT) has emerged as a promising intervention for alcohol use disorder (AUD), yet contemporary clinical evidence has not been systematically synthesized to validate its clinical utility and safety profile. Methods: Contemporary clinical trials of PAT for AUD were identified systematically from PubMed, PsycINFO, and Scopus by two independent reviewers....

Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy

Therapeutic Advances in Psychopharmacology October 8, 2026 Gianluca A. Florineth, Anna L. Boeker, Felix Müller et al.

Background Classic psychedelics show potential for treating psychiatric disorders, yet the psychological framework of psychedelic-assisted therapy (PAT) remains underspecified. As regulatory approval approaches, defining the contribution of psychological interventions to clinical outcomes is critical for both mechanism inference and implementation. Objectives To systematically review the...

[Interventional psychiatric procedures and novel substances for the treatment of affective disorders: An overview and outlook].

Therapeutische Umschau April 1, 2025 Tobias Bracht, Daniela Hubl, Kristina Adorjan et al. 1 citation

Depression is one of the most common mental disorders. The effectiveness of pharmacological and psychotherapeutic treatments is well documented. Remission rates are around 67 % for pharmacological antidepressant initial and secondary treatment of a depressive episode in unipolar disorders. However, patients with a depressive episode who do not respond to at least two successive attempts at...

DOI: 10.23785/TU.2025.02.005 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Electroconvulsive therapy ect Ketamine/esketamine Depression therapy innovations +3